Skip to main content

Table 1 Pre- and post-operative characteristics of patients with absence or presence of lymph nodes in PAFP

From: Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study

 

LN absent in PAFP

LN present in PAFP

P-value

(N = 7891)

(N = 909)

Age, years: mean (SD)

62.7 (7.5)

62.9 (7.7)

0.413

BMI, kg/m2 :mean (SD)

27.9 (3.7)

27.9 (4.2)

0.814

PSA, ng/ml: mean (SD)

8.84 (12.32)

10.00 (24.62)

0.107

Categorical PSA, ng/ml: %

  

0.814

 0-3.9

20.0

22.0

 

 4-9.9

58.3

56.2

 

 10-20

15.1

14.0

 

 >20

6.7

7.8

 

Biopsy GS: %

  

<0.001

 6-7

82.8

78.3

 

 8-10

17.2

21.7

 

Pathologic GS: %

  

0.307

 6-7

83.8

82.1

 

 8-10

16.7

17.9

 

Pathologic T stage: %

  

0.659

 T2≥

67.5

66.8

 

 T3≤

32.5

33.2

 

Pathologic N stage: %

 

0.001

 N0/Nx

96.0

93.5

 

 N1

4.0

6.5

 

Margin status: %

  

<0.001

 Negative

82.3

78.1

 

 Positive

17.7

21.9

 
  1. PAFP, Prostate anterior fat pad; LN, Lymph node; BMI, Body mass index; PSA, Prostate-specific antigen; GS, Gleason score